ABEO
Price
$7.01
Change
+$0.03 (+0.43%)
Updated
Jul 13 closing price
Capitalization
399.31M
29 days until earnings call
Intraday BUY SELL Signals
AURA
Price
$7.00
Change
+$0.16 (+2.34%)
Updated
Jul 13 closing price
Capitalization
723.02M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABEO vs AURA

ABEO vs AURA Comparison Chart in %
View a ticker or compare two or three
VS
ABEO vs. AURA commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a StrongBuy and AURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ABEO: $7.01 vs. AURA: $7.00)
Brand notoriety: ABEO and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABEO: 76% vs. AURA: 59%
Market capitalization -- ABEO: $399.31M vs. AURA: $723.02M
ABEO [@Biotechnology] is valued at $399.31M. AURA’s [@Biotechnology] market capitalization is $723.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABEO’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 0 green FA rating(s).

  • ABEO’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ABEO is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABEO’s TA Score shows that 6 TA indicator(s) are bullish while AURA’s TA Score has 5 bullish TA indicator(s).

  • ABEO’s TA Score: 6 bullish, 4 bearish.
  • AURA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ABEO is a better buy in the short-term than AURA.

Price Growth

ABEO (@Biotechnology) experienced а +11.09% price change this week, while AURA (@Biotechnology) price change was -1.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

ABEO is expected to report earnings on Aug 12, 2026.

AURA is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($723M) has a higher market cap than ABEO($399M). ABEO YTD gains are higher at: 33.017 vs. AURA (28.440). ABEO has higher annual earnings (EBITDA): 73.4M vs. AURA (-117.51M). ABEO has more cash in the bank: 168M vs. AURA (115M). AURA has less debt than ABEO: AURA (17M) vs ABEO (23.2M). ABEO has higher revenues than AURA: ABEO (14.5M) vs AURA (0).
ABEOAURAABEO / AURA
Capitalization399M723M55%
EBITDA73.4M-117.51M-62%
Gain YTD33.01728.440116%
P/E Ratio7.37N/A-
Revenue14.5M0-
Total Cash168M115M146%
Total Debt23.2M17M136%
FUNDAMENTALS RATINGS
ABEO: Fundamental Ratings
ABEO
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
16
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABEOAURA
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 20 days ago
78%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ABEO
Daily Signal:
Gain/Loss:
AURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDQX15.680.06
+0.38%
Artisan Mid Cap Value Advisor
AVPAX27.39N/A
N/A
American Beacon Small Cp Val Inv
HMVSX20.28N/A
N/A
Hartford MidCap Value R4
EVDAX22.01N/A
N/A
Camelot Event Driven A
CNGAX83.46-2.15
-2.51%
American Funds New Economy 529-A

ABEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with AVBP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then AVBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
+0.43%
AVBP - ABEO
44%
Loosely correlated
-0.15%
IMTX - ABEO
43%
Loosely correlated
-4.65%
SLDB - ABEO
42%
Loosely correlated
-6.72%
AURA - ABEO
41%
Loosely correlated
+2.34%
RGNX - ABEO
40%
Loosely correlated
-8.60%
More

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
+2.34%
MGTX - AURA
45%
Loosely correlated
-7.84%
RCUS - AURA
44%
Loosely correlated
-2.94%
CADL - AURA
44%
Loosely correlated
+1.58%
VIR - AURA
44%
Loosely correlated
-2.41%
MLTX - AURA
44%
Loosely correlated
+0.25%
More